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Open Access

A cluster randomized controlled trial
comparing Virtual Learning Collaborative
and Technical Assistance strategies to
implement an early palliative care program
for patients with advanced cancer and their
caregivers: a study protocol
Lisa Zubkoff1,2* , Kathleen Doyle Lyons3,4, J. Nicholas Dionne-Odom5,6,7, Gregory Hagley3, Maria Pisu1,7,
Andres Azuero1,5,6, Marie Flannery8, Richard Taylor5,6, Elizabeth Carpenter-Song9, Supriya Mohile8† and
Marie Anne Bakitas5,6,7†

Abstract
Background: Virtual Learning Collaboratives (VLC), learning communities focused on a common purpose, are used
frequently in healthcare settings to implement best practices. Yet, there is limited research testing the effectiveness
of this approach compared to other implementation strategies. This study evaluates the effectiveness of a VLC
compared to Technical Assistance (TA) among community oncology practices implementing ENABLE (Educate,
Nurture, Advise, Before Life Ends), an evidence-based, early palliative care telehealth, psycho-educational
intervention for patients with newly diagnosed advanced cancer and their caregivers.
Methods: Using Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) and Proctor’s
Implementation Outcomes Frameworks, this two-arm hybrid type-III cluster-randomized controlled trial (RCT) will
compare two implementation strategies, VLC versus TA, among the 48 National Cancer Institute Community
Oncology Research Program (NCORP) practice clusters that have not historically provided palliative care to all
patients with advanced cancer. Three cohorts of practice clusters will be randomized to the study arms. Each
practice cluster will recruit 15–27 patients and a family caregiver to participate in ENABLE. The primary study
outcome is ENABLE uptake (patient level), i.e., the proportion of eligible patients who complete the ENABLE
program (receive a palliative care assessment and complete the six ENABLE sessions over 12 weeks). The secondary
(Continued on next page)

* Correspondence: lisazubkoff@uabmc.edu
†
Supriya Mohile and Marie Anne Bakitas are co-senior authors
1
Division of Preventive Medicine, Department of Medicine, University of
Alabama at Birmingham, Birmingham, AL, USA
2
Birmingham/Atlanta VA Geriatric Research Education and Clinical Center
(GRECC), Department of Veterans Affairs, Birmingham, AL, USA
Full list of author information is available at the end of the article
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.

Zubkoff et al. Implementation Science

(2021) 16:25

Page 2 of 16

(Continued from previous page)

outcome is overall program implementation (practice cluster level), as measured by the General Organizational
Index at baseline, 6, and 12 months. Exploratory aims assess patient and caregiver mood and quality of life
outcomes at baseline, 12, and 24 weeks. Practice cluster randomization will seek to keep the proportion of rural
practices, practice sizes, and minority patients seen within each practice balanced across the two study arms.
Discussion: This study will advance the field of implementation science by evaluating VLC effectiveness, a
commonly used but understudied, implementation strategy. The study will advance the field of palliative care by
building the capacity and infrastructure to implement an early palliative care program in community oncology
practices.
Trial registration: Clinicaltrials.gov. NCT04062552; Pre-results. Registered: August 20, 2019. https://clinicaltrials.gov/
ct2/show/NCT04062552?term=NCT04062552&draw=2&rank=1
Keywords: Implementation strategies, Implementation science, Early palliative care, Advanced cancer, Clusterrandomized controlled trial

Contributions to the literature
 As recommended by oncology professional organizations,
this study will promote the use of an evidence-based, telehealth, early palliative care program for patients with advanced cancer among a national sample of community
oncology practices.

 Improve understanding of effectiveness of two commonly
used implementation strategies, the Virtual Learning
Collaborative (VLC) and Technical Assistance (TA).

 Evaluates measures of ENABLE implementation,
organizational factors that influence fidelity to
implementation, and patient and caregiver outcomes.

 Lessons learned will inform measurement of multi-level implementation outcomes related to early palliative care
interventions.

 Lessons learned will inform future use of telehealth
interventions and virtual implementation strategies.

Introduction
Background and rationale

Due to the benefits of early palliative care (EPC) in randomized controlled trials [1–3], the American Society of
Clinical Oncology recommends “ … combined standard
oncology care and palliative care … early in the course
of illness for any patient with metastatic cancer and/or
high symptom burden” [4] (p.881). Yet, the National
Cancer Institute (NCI)’s “Landscape Study” revealed that
only 30% of community oncology practices have access
to palliative care multidisciplinary teams in outpatient
settings [5, 6]. Even practices offering EPC are often unable to meet the needs of all advanced cancer patients
due to a limited palliative care workforce and the large
number of patients with advanced cancer and caregivers
[7, 8]. Training existing oncology staff to provide

evidence-based palliative care interventions [9] is a potentially scalable and sustainable approach to address
the national shortage of palliative care specialists. The
ENABLE (Educate, Nurture, Advise, Before Life Ends)
program is an example of such an intervention that can
be implemented by healthcare organizations seeking to
develop or enhance palliative care services.
ENABLE is an evidence-based, scalable model of EPC
promoted by the National Cancer Institute EvidenceBased Cancer Control Programs (EBCCP), formerly
known as Research-Tested Intervention Program (RTIP)
[10–12]. ENABLE is led by a Nurse Coach and includes
a comprehensive palliative care assessment, weekly telehealth coaching sessions (6 for patient; 3 for caregiver)
using the Charting Your Course© guidebook. The
coaching sessions review essential palliative care topics,
such as problem solving, coping, symptom management,
self-care, communication, decision-making, and advance
care planning and monthly follow-up calls (Fig. 1). The
parallel ENABLE program topics for caregivers mirror
the patient sessions. ENABLE has not been widely used
in community oncology practices despite being publicly
available through the EBCCP. An effective implementation strategy to address implementation barriers (e.g.,
lack of knowledge about evidence-based EPC, insufficient infrastructure) is needed to equip oncology practices to develop the skills to implement and sustain
ENABLE. However, it is unclear which strategy would
be most successful in assisting implementation.
Two common strategies to enhance implementation of
evidence-based practices include VLC and TA. VLC is an
innovative version of the traditional (face-to-face) Learning Collaborative, developed by the Institute for Healthcare Improvement (IHI) to guide clinical teams in
implementing evidence-based practices [13]. Learning collaboratives use group interaction among teams to guide
clinical improvement efforts. VLC, which uses a virtual
(web-based) platform instead of face-to-face meetings,
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Fig. 1 Charting your course (CYC) chapter/session topics

was designed to decrease the cost of participation and increase the speed of incorporating lessons into practice [14,
15]. The evidence on VLCs appears to improve processes,
but is inconclusive on outcomes [16, 17].
The second strategy, TA, is defined as “interactive support that is individualized to the specific needs of individuals or teams.” (p.3) [18]. TA is typically provided
one-on-one to a single organization and does not use a
community structure to encourage shared learning or
collaboration [19]. The evidence on TA effectiveness is
minimal [19, 20]. To our knowledge, there are few rigorous trials comparing the effectiveness of VLC or TA and
more testing with rigorous study design is needed [14,
15, 21, 22]. Which strategy would be most effective for
the widespread implementation of ENABLE in community oncology practices is unclear.
To address these gaps in implementation science and
palliative care, we developed a cluster randomized controlled trial (RCT) that compares VLC to TA for implementing ENABLE in community oncology practices.
Our primary hypothesis is that practices randomized to
VLC will outperform those randomized to TA resulting

in a higher proportion of patients completing the ENABLE program. The more effective implementation of
ENABLE will be due to the benefits of group dynamics
(e.g., shared experiences, accountability, learning, discussion, and interactions), and quality improvement learning/skills that occur in the VLC but not in TA.
Ultimately, a greater uptake of ENABLE will lead to better outcomes (mood and quality of life) for the patients
and caregivers at the practices exposed to VLC compared to those exposed to TA.
Study aims and hypotheses

Based on Proctor’s implementation framework, the purpose of this two-arm hybrid type-III cluster RCT in
community oncology practices is to compare the effectiveness of two strategies, VLC and TA for implementing
the evidence-based ENABLE program (Fig. 2).
Primary aim (implementation outcome, patient level)

Compare the effectiveness of VLC vs. TA on ENABLE
program uptake, as measured by the proportion of patients who complete the ENABLE program (i.e., have a
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Fig. 2 Adapted proctor’s implementation outcomes model applied to study aims

palliative care assessment and complete the six ENABLE
sessions). Hypothesis: Practice clusters randomized to
VLC will have greater ENABLE program uptake than
practice clusters randomized to TA.

Secondary aim (service outcome, practice level)

Compare the effectiveness of VLC vs. TA on practice clusters’ overall ENABLE program implementation. This will
be assessed using the ENABLE General Organizational
Index (GOI), which measures factors that influence institutional implementation of evidence-based practices. Hypothesis: Practice clusters randomized to VLC will have
better overall ENABLE program implementation than
practice clusters randomized to TA.

Methods/design
Theoretical framework

This study is guided by the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework, which is designed to enhance the quality, speed,
and public health impact of efforts to translate research
into “real world” settings [23, 24]. Further, this study applies Proctor’s Implementation Outcomes framework
[25] to assess implementation success via outcomes on
three levels: implementation (effects of actions to implement new treatment), service (reflect the practice
process changes), and client (evidence-based program’s
effect on the target population).

Trial design
Exploratory aim 1 (patient & caregiver outcomes)

Compare practice clusters randomized to VLC or TA on patient and caregiver quality of life (QOL) and mood outcomes.
Hypothesis: Patients and caregivers at practice clusters randomized to VLC will have better QOL and mood compared
to those at practice clusters randomized to TA.

Exploratory aim 2

Determine the relationship among ENABLE program
uptake, overall ENABLE program implementation,
and patients’ QOL and mood across the two strategies. Hypothesis: Practice clusters with better ENABLE program uptake and overall ENABLE
implementation (regardless of implementation group)
will demonstrate a higher degree of improved patient
outcomes (i.e., QOL and mood) compared to practice
clusters that have low/poor ENABLE program uptake
and overall ENABLE implementation.

This two-arm hybrid type-III cluster RCT compares implementation strategy effectiveness, while gathering additional information on the ENABLE program outcomes
[26–28]. VLC and TA have distinct communication
channels, time requirements, social systems, and structures [29, 30]. A target sample of 48 NCI’s Community
Oncology Research Program (NCORP) practices will be
randomized to one of two conditions: 1) VLC group
which will receive ENABLE training and participate in a
15-month VLC (n = 24) or 2) TA group which will receive ENABLE training and participate in a 15-month
TA process (n = 24). Each NCORP practice in this study
will be formed into “practice clusters.” Practice cluster is
defined as an NCORP practice location where oncology
physicians and study staff work independently and do
not crossover to another practice. Practice clusters will
be recruited in 3 cohorts of approximately 16 practice
clusters per cohort. In each cohort half of the practice
clusters will be randomized to VLC and half will be randomized to TA (Fig. 3).
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Fig. 3 Trial design

Setting/sample
URCC NCORP practice cluster participation

This study is being carried out from the University of
Rochester Cancer Center (URCC) NCORP Research
Base. NCORP is a national network that brings cancer
treatment and care delivery trials to people in community settings. NCORP is comprised of 7 Research Bases,
and 46 Community Affiliates, each with affiliated practices [31]. The URCC NCORP Research Base is associated with 22 NCORPs and 358 sub-affiliates across the
country. URCC NCORP practices vary in size and geographic location; however, to be eligible to participate in
this study, they must meet the following inclusion
criteria:
 Identify two (or more) Nurse Coaches to deliver the

ENABLE program. For practices that only have 1
nurse available, one Nurse Coach is allowed.

 Commitment of Nurse Coaches to be trained to







conduct the palliative care assessment and deliver
the ENABLE sessions
Desire to implement ENABLE, including presence of an
investigator (e.g., Primary Affiliate Principal Investigator,
oncology physician, Cancer Care Delivery Research
(CCDR) Lead) and/or program administrator/supervisor
who are willing to be key contacts
Demonstrated support/buy-in from oncology
physicians who are willing to enroll patients
Agreement of practice leadership and staff to
support/participate in study activities
If necessary, willingness to participate in a phone
interview to determine capacity to implement the
ENABLE program.

Exclusion criteria Practice clusters that currently offer
fully functioning inter-professional early palliative care
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to all cancer patients will be excluded. If practices offer
early palliative care services to some, but not to all cancer patients, practices will only enroll patients to this
study who have not received early palliative care
services.

palliative care services, demographics of patient population, staff members to be involved in the study) and submit it to URCC Research Base. Each practice cluster will
be expected to enroll and deliver ENABLE to 15–27
patients.

Within practice cluster patients and caregivers
participants
Patients

Patient and caregiver recruitment

Patients will be encouraged (but not required) to select a
caregiver, defined below, to participate in the study. Participants can receive cancer treatment while participating in the study but will not have received palliative care
services at the time of enrollment.
Patient inclusion criteria Patients must be diagnosed
with advanced cancer (stage III/IV, recurrence, or progressive solid tumor cancer) within the last 90 days and
have an expected survival of at least 6 months. Patients
must be English-speaking, at least 18 years old, willing to
complete the palliative care assessment and ENABLE
sessions, have access to a telephone that can receive
calls, and able to provide informed consent to participate
in the study.
Patient exclusion criteria Patients who received previous palliative care services will be excluded. However,
after enrollment, patients may receive palliative care services outside of the ENABLE program, if appropriate.
Caregivers

Each patient can identify a single caregiver to participate
in the study. The caregiver is any person who provides
support to the patient. Caregivers may remain in the
study even if the patient withdraws.
Caregiver inclusion criteria Caregivers are defined as
an “unpaid relative or friend who knows them well and
who provides regular support to their cancer.” Caregivers must be English-speaking, at least 18 years old,
willing to complete the ENABLE Caregiver program sessions, have access to a telephone that can receive calls,
and able to provide informed consent to participate in
the study.
Exclusion criteria None.
Practice cluster recruitment

The URCC NCORP Research Base will announce the
study via email to all URCC NCORP community affiliates and post study activation on the Cancer Trials Support Unit (CTSU) website. In addition, we will hold
information webinars. Interested practice clusters will
complete a form to describe the practice (e.g., current

Staff in each practice cluster will identify eligible patients
from clinical schedules and inform oncology physicians.
If the physician determines the patient to be eligible and
the patient agrees to be informed about the study, study
personnel at the practice (e.g., Nurse Coach, research
coordinator) will meet the patient either in person or via
HIPAA compliant phone or videoconference to review
the study. Informed consent will be obtained either in
person or using a HIPAA compliant phone or videoconference and documented.
Evidence-based practice to be implemented: ENABLE

The ENABLE program for patients consists of [1] a standardized in-person or telehealth Palliative Care Assessment [32] and [2] a series of six, 20–60 min weekly
telephone coaching sessions provided by a Nurse Coach
using the Charting Your Course© (CYC) guidebook [33,
34]. ENABLE fosters patient empowerment [35, 36]
through coaching on problem-solving coping, symptom
management, self-care, communication, decisionmaking, and life review and reflection. A Nurse Coach,
who is a registered nurse or advanced practice provider
(e.g., nurse practitioner or physician assistant) who has
at least 2 years’ experience working in oncology or palliative care, delivers the ENABLE program. Caregivers
receive a separate series of similar telephone sessions
using a CYC© guidebook with caregiver-relevant content. After completing the weekly sessions, both the patient and caregiver receive monthly check-in phone calls.
Figure 1 presents the CYC© session topics. Trials testing
ENABLE have demonstrated improved patient quality of
life, mood, and survival outcomes and reduced caregiver
burden and improved mood [10, 11, 37].
Implementation interventions (practice cluster level)

Table 1 summarizes the essential elements of the VLC
and TA implementation strategies and outlines the distinctive features between the two. Each practice cluster
will assemble an implementation team who will participate in the assigned implementation strategy (VLC or
TA). At minimum, this includes one or two Nurse Coaches who will deliver the intervention and at least one
coordinator who will facilitate recruitment and patient
and caregiver outcome assessment. Other members of
the practice cluster (e.g., oncologists, data managers) are
also encouraged to participate in implementation team
and VLC or TA activities.
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Table 1 Summary of Implementation Strategies
Activity

Virtual Learning Collaborative (VLC)

Technical Assistance (TA)

Form an ENABLE Implementation Team

✓

✓

ENABLE training

✓

✓

ENABLE Implementation (15 months)

Group web-based VLC learning sessions
(monthly)

Individual practice cluster consultation call with ENABLE
expert (monthly)

Coaching/Expert Consultation

✓

✓

Quality Improvement Knowledge and
Information

✓

Individualized Written Feedback

✓

Monthly Group Discussion and Sharing

✓

Between Session Activities

✓

Virtual Learning Collaborative

Practice clusters randomized to the 15-month VLC will
participate in monthly virtual group-based learning sessions to discuss key components of the ENABLE program, implementation progress (e.g., nurse coach
training, number referrals, number patients/caregivers
enrolled, sessions completed), data collection activities,
and current successes and challenges. In addition, the
VLC will include instruction on quality improvement
tools and techniques to assist with the implementation
process, coaching, and the opportunity to share stories
and experiences and learn from other practice clusters
using an “all teach, all learn” approach [13]. The VLC
will be co-led by ENABLE and quality improvement experts (RT and KDL).
TA

Practice clusters randomized to the 15-month TA study
arm will receive individual, interactive monthly consultation calls with an ENABLE expert (JND-O). The TA
leader will ask similar questions about the practice cluster’s implementation progress as are covered in the VLC
study arm (e.g., nurse training, referral process, enrollment, sessions completed, data collection activities, and
current successes and challenges). The relationship between the TA provider (JND-O) and practice clusters
will be friendly, trusting, strengths-based, collaborative,
and will support practice cluster autonomy. We anticipate that practice clusters will solicit input or guidance
from the TA leader on challenges or areas of concern.
The TA leader will offer advice and suggestions to the
degree desired by the practice cluster.

deliver each ENABLE session; [3] role play of the assessment and phone sessions that will be reviewed by an
ENABLE expert who will provide feedback; and [4] tools
and resources for Nurse Coaches. Upon completion of
the ENABLE training, Nurse Coaches will complete an
evaluation of the training to receive Continuing Education Unit (CEU) credits.
Additional trainings will cover study procedures and
how to use the web-based study platforms: Canvas,
Zoom, and Research Electronic Data Capture (REDCap),
an electronic data capture tool to enter study data.
Measures and outcomes

Based on Proctor’s Framework (Table 2), this study has
3 categories of outcomes [1] implementation (aim 1), [2]
service (aim 2), and [3] client (patient and caregiver)
outcomes (exploratory aim 1).
Aim 1: ENABLE uptake (implementation outcome, patient
level)

The primary outcome will be ENABLE program uptake
(program completion). To capture ENABLE program
uptake, each ENABLE Nurse Coach will use a standardized ENABLE Nurse Coach Contact Log to document
patient and caregiver referrals, enrollment, and completion of the essential ENABLE elements (i.e., palliative
care assessment, ENABLE sessions). The Nurse Coach
Contact Log, which is completed in REDCap, will document each contact and ENABLE session using an
assigned study identification for each patient or
caregiver.

Study trainings

Aim 2: Overall ENABLE Program implementation (service
outcome, practice cluster level)

Nurse Coaches who deliver the ENABLE program will
complete the approximately 19-h self-paced 10-module
ENABLE training on a web-based platform (Canvas).
The training, developed by ENABLE experts, consists of
[1] an overview of the ENABLE program; [2] instruction
on how to conduct the palliative care assessment and

This outcome will be measured for each practice cluster
via phone interviews with Nurse Coaches and coordinators using the ENABLE General Organizational Index
(GOI). This instrument was developed to assess factors
that influence institutional implementation of the ENABLE program [38]. We previously adapted [38] the
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Table 2 Measures and outcomes
Outcome

Instrument(s)

Time
Point

Target

Description

Months
1-15

Coordinator or Nurse
Coach

This contact log documents the delivery of each
ENABLE session.

Coordinator and Nurse
Coach (other staff may
attend call)

The ENABLE General Organizational Index (GOI) is
conducted via a phone interview with the Coordinator
and Nurse Coach (other staff may attend call) to assess
factors that influence institutional implementation and
fidelity to an evidence-based practice. It covers 12 domains and is scored on a Likert scale. Qualitative analysis
will also be conducted [38–40].

Aim 1 Outcome (Implementation Outcome, Patient Level)
ENABLE Uptake

ENABLE Nurse Coach Contact
Log (patients and caregivers)

Aim 2 Outcome (Service Outcome, Practice Level)
Overall Program
Implementation

ENABLE GOI

Baseline,
6, 12
months

ENABLE Program
Implementation

ENABLE RE-AIM Self-Assessment
Tool

Baseline,
6, 12
months

Coordinator and Nurse
Coach

The ENABLE RE-AIM Self Assessment Tool (Reach, Efficiency, Adoption, Implementation, and Maintenance)
was developed in our prior work to collect reach, adoption, implementation, and maintenance [23, 24, 38].
Reach is defined as the number of enrolled participants
divided by the number of eligible participants. Efficacy
will be measured by patient and caregiver quality of life
and mood outcomes (see Explanatory Aim 1 measures).
Adoption will be measured by calculating the number of
oncology physicians who refer patients divided by those
who have the opportunity to refer patients to the study.
Implementation is captured in the study’s primary outcome, ENABLE uptake. Maintenance will be measured by
the presence of the ENABLE program 6 months after the
completion of the VLC or TA implementation strategy in
the ENABLE Sustainment Survey. The ENABLE Nurse
Coach and/or coordinator will complete the online ENABLE RE-AIM Self-Assessment tool at baseline, 6 months
(± 8 weeks), and 1 year (± 8 weeks).

Baseline,
15
months

Oncologist and Nurse
Coach

The survey asks about attitudes about palliative care,
feelings about palliative care specialists, comfort with an
preferences for providing early concurrent oncology
palliative care, and description of early concurrent
palliative care provided in the practice cluster [38, 41].
Responses are on a Likert scale.

Additional Implementation Outcomes

Perceptions of
Provider Perceptions of Early
Early Palliative Care Palliative Care Survey

VLC and TA Process Outcomes
Program
Participation and
Engagement (VLC
or TA)

VLC Practice Participation and
Engagement; TA Practice
Participation and Engagement

Months
1-15

Study team (VLC lead,
TA lead)

The VLC and TA Participation and Engagement forms
assess the extent to which the sites participate in the
assigned strategy (VLC or TA). The forms share
commonalities, but are distinct to reflect the different
methods of communicating with practice clusters. The
site’s level of participation in the session is scored on a
Likert scale with an additional free text entry. A higher
score indicates better participation and engagement.

Fidelity (VLC or TA) VLC Fidelity; TA Fidelity

Months
1-15

Study team (VLC lead,
TA lead)

The instrument measures fidelity and adherence to key
features of the VLC and TA study arms respectively. The
forms will be completed after each session. The
instrument for the VLC and TA study arm are distinct.
The study team will audit 10% of sessions by reviewing
the recording and verifying key components being
discussed during sessions.

Palliative Care
Assessment

Palliative Care Assessment
Checklist

Baseline

Additional ENABLE
Contacts

ENABLE Additional Contacts Log Months
(patients and caregivers)
1-15

ENABLE Process Measures
Nurse Coach

This form documents each of the key components of
the palliative care assessment that are completed.

Coordinator and Nurse
Coach

This instrument tracks other patient and caregiver
contacts or activities as part of the ENABLE program.
The ENABLE Nurse Coach will document non-session
contacts and activities each week (i.e., time spent doing
ENABLE related study tasks other than delivering the
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Table 2 Measures and outcomes (Continued)
Outcome

Instrument(s)

Time
Point

Target

Description
sessions) and enter them into REDCap. The coordinator
will also document the time to complete recruitment
and enrollment procedures in the log on REDCap every
2 weeks.

Fidelity to Palliative Palliative Care Assessment
Care Assessment
Adjudication Checklist

Baseline,
months
4-6

Nurse Coach

An ENABLE expert will review four of each practice
cluster’s palliative care assessments to ensure
completion and correct documentation. At each
practice cluster, we will request the clinical note in the
medical record associated with the palliative care
assessment for the first two patients enrolled and then a
random sample of two additional patients. Study
personnel will review the note and compare it to the
Palliative Care Assessment Checklist. Adequate fidelity
will be demonstrated by ≥85% of the components
identified on the Palliative Care Assessment Checklist.

ENABLE
Sustainment

Month
21

Oncologist and Nurse
Coach (may be
completed by other
staff)

This 9-item instrument measures the presence/sustainment of the ENABLE program 6 months (± 4 weeks)
after completion of the 15-month implementation strategy (VLC or TA). Example questions include the number
of trained ENABLE Nurse Coaches, number of patient
and caregiver participants, ENABLE components currently offered, and any adaptations that have been
made to the ENABLE program. Other staff members
(e.g., coordinator, Primary Affiliate PI, CCDR Lead) may
also complete the survey.

ENABLE Sustainment Survey

Exploratory Aim 1 Outcome (Patient Outcomes)
Patient Mood

HADS

Baseline,
12, 24
weeks

Patient

The Hospital Anxiety and Depression Scale (HADS)
instrument assesses mood, including anxiety and
depression. Seven questions rate the depression
subscale and 7 questions rate the anxiety subscale. Each
item has a 4-point scale, ranging from 0 to 3 with possible scores ranging from 0-21 for each subscale. Scoring
for each sub-scale is as follows: 0-7 Normal, 8-10 Borderline abnormal, and 11-21 Abnormal [42–46].

Patient Quality of
Life

FACIT-PAL

Baseline,
12, 24
weeks

Patient

The FACIT-Pal consists of the FACT-G (Functional Assessment of Cancer Therapy-General), a general measure of
quality of life, and the palliative care subscale (Pal),
which assesses issues specifically relevant to palliative
care [37, 47–49]. The FACT-G is a 27-item questionnaire
that provides a total score as well as four subscale
scores: physical, social/family, emotional, and functional
wellbeing. The FACIT-Pal includes 19 additional concerns
relevant for persons at the end of life. The total score is
the sum of the FACT-G plus the FACIT-Pal subscale [50].

Patient Global
Health

PROMIS Global Health

Baseline,
12, 24
weeks

Patient

The 10-item measure uses Likert-scale response options
for each item, ranging from 1 (always) to 5 (never). This
instrument produces 2 scores: physical health and mental health score [51–54].

Symptom burden

MDASI

Baseline,
12, 24
weeks

Patient

The MD Anderson Symptom Inventory (MDASI) is a 19item measure that assesses symptom severity experienced by patients with cancer and the symptom-related
interference with daily living [55, 56]. The MDASI uses a
0-10 severity scale for 13 items, with 0 being symptom
“not present” and 10 being “the worst you can imagine,”
and an interference 0-10 response scale for 6 items ranging from 0 being “did not interfere” to 10 being “interfered completely”.

Demographic and
Clinical
Characteristics

Demographics Form

Baseline

Patient

Patients will be asked to report their education level,
marital status, whom they live with, employment status,
age, gender, ethnicity, race, employment status,
diagnosis, insurance status, annual household income,

Additional Patient Outcomes
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Table 2 Measures and outcomes (Continued)
Outcome

Instrument(s)

Time
Point

Target

Description
urban vs. rural living location, religious preference,
presence of a living companion, prior and current
smoking status and usage, prior and current alcohol
consumption.

Exploratory Aim 1 Outcome (Caregiver Outcomes)
Caregiver Mood

HADS

Baseline,
12, 24
weeks

Caregiver

See description under Patient Outcomes.

Caregiver Quality
of Life

PROMIS Global Health

Baseline,
12, 24
weeks

Caregiver

See description under Patient Outcomes.

Caregiver burden

MBCB

Baseline,
12, 24
weeks

Caregiver

The Montgomery Borgatta Caregiver Burden (MBCB)
Scale is a 14-item instrument assesses caregiver burden
and the impacts on the caregiver’s life [57–59]. Each
item uses a Likert-type scale response option, ranging
from 1 (“A lot less”) to 5 (“A lot more”).

Positive Aspects of
Caregiving

Positive Aspects of Caregiver

Baseline,
12, 24
weeks

Caregiver

The Positive Aspects of Caregiver is a 9-item instrument
that assesses positive aspects of caregiving, including
the extent to which the caregiver feels: useful, good
about him/herself, needed, appreciated, important,
strong and confident, appreciates life, more positive attitude toward life, and strengthened relationships with
others. Each item is rated on a 5-point ordinal scale ranging from 1 (disagree a lot) to 5 (agree a lot) [60].

Preparedness for
Caregiving

Preparedness for Caregiving
Scale

Baseline,
12, 24
weeks

Caregiver

The Preparedness for Caregiving Scale is a self-rated instrument that consists of 8-items that asks caregivers
about their perceived preparedness for multiple domains of caregiving, such as providing physical care,
providing emotional support, setting up in-home support services, and dealing with the stress of caregiving
[61, 62]. Responses are rated on a 5-point scale with
scores ranging from 0 (not at all prepared) to 4 (very
well prepared) [63]. There is also a question with a free
text response.

Demographics

Demographic Form

Baseline

Caregiver

Caregivers will also be asked to report education level,
marital status, whom they live with, employment status,
age, gender, ethnicity, race, employment status,
insurance status, annual household income, urban vs.
rural living location, religious preference, relationship to
patient participant, if the patient participants lives with
them, average number of days per week they help take
care of the patient, and average hours per day helping
the patient participant.

General Organizational Index (GOI) which measures fidelity to an evidence-based practice by assessing two key
elements of implementation: individualization and quality improvement [64]. The GOI has been shown to have
acceptable psychometric properties [39]. The ENABLE
GOI structured interview guide covers 12 domains (program philosophy, eligibility/client identification, penetration, assessment, individualized initial palliative care
treatment plan, individualized subsequent ENABLE contacts, supervision, process monitoring, outcome monitoring, quality assurance, and client choices regarding
service provision) associated with successful implementation. ENABLE GOI assessments will occur at baseline,
6 months (± 8 weeks), and 1 year (± 8 weeks). After the

phone interview, the interviewer [40] will score each domain on a Likert scale for a total range of 12–60. Moreover, interviews will be recorded and transcribed for
qualitative analysis to augment quantitative assessment
of this outcome.
Table 2 presents additional implementation measures,
including RE-AIM, process outcomes for the study arms
(VLC and TA), and ENABLE process measures.
Exploratory aim: patient measures

Table 2 presents patient measures. Patient assessments
will be completed at baseline, 12, and 24 weeks. There
will be several options to collect the data: [1] study coordinator reads the questions to the patient (either in
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person or on the phone) and enters the patient responses, [2] the patient completes the assessments in
person with a study coordinator, or [3] the patient will
take a paper copy home, complete it, and return it at either the next visit, via mail, or scan and email.
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baseline characteristics (e.g., age, sex, race, cancer type,
stage) using effect sizes, such Cohen’s d and Cramer’s.
Factors showing non-trivial imbalances between comparators will be used as adjusting covariates in the
between-group comparisons. Analysis will be conducted
using the latest versions of SAS and R.

Exploratory aim: Caregiver measures

Caregiver assessments (Table 2) will be completed at
baseline, 12 and 24 weeks using the same methods as for
patients described above.
Sample size
Aim 1: Implementation outcome (patient level)

The RCT is powered for the aim 1 outcome, ENABLE
program uptake, defined as the proportion of patients
who complete the ENABLE program. In determining the
targeted sample size, we made the following assumptions: [1] an intra-class correlation coefficient (ICC)
value of 0.05, [2] alpha of 1% (α = 0.01) and 80% power,
[3] 20% enrolled patients for whom completion of ENABLE cannot be assessed due to death or becoming too
ill to continue with participation, and [4] a proportion of
patients completing ENABLE of 0.52 in prior studies.
With 24 practice clusters per group and a minimum of
12 patients per practice cluster (down from 15 after 20%
unable to assess completion), for a total of 288 patients
per group, the detectable difference in ENABLE program
uptake is 0.18 (OR = 2.06; RR = 1.33), a medium effect
size.
Randomization

This cluster-randomized trial will be carried out in 3 sequential cohorts of 8–20 practice clusters (4–10 per
study arm) to reach the desired sample size of 48 practice clusters. Within each cohort, RCT arm assignment
will occur after completion of all required study trainings, including the ENABLE training (Fig. 3). A
minimization algorithm for group assignment with random initial start will be used to attempt to simultaneously balance the proportion of rural practices, practice
sizes, and minority patients seen within each practice
across the two RCT arms. The minimization algorithm
will be generated using R software. Study team members
and practice cluster members will not be blinded to
group assignment or study hypotheses.
Statistical analysis

All randomized practice clusters will be included in primary comparisons, according to their group assignment,
and regardless of their degree of participation in the
study. Primary data analysis will include descriptive statistics for baseline practice cluster characteristics, patient
characteristics, and outcomes in each RCT arm. We will
examine the balance between RCT arms with respect to

Analysis for aim 1: Implementation outcome (patient level)

We will use a logit GEE model with exchangeable correlation structure (to account for clustering within practice) for the binary patient uptake indictor (“yes” if the
patient completed a palliative care assessment and all
ENABLE program sessions prior to the 12 week assessments and “no” if the patient is still alive but has not
completed a palliative care assessment and all six ENABLE program sessions prior to the 12-week assessments), with the group assignment as the main
predictor. Model-predicted outcome proportions, odds
ratios, relative risks, and confidence intervals for these
measures will be used for interpretation. Supplemental
analyses using appropriate methods for clustered data
will consist of between-group comparisons of the proportion of recruited patients who could not complete
the ENABLE sessions due to illness or death, and the
number of sessions completed among all patients
recruited.
Analysis for aim 2: Service outcome (practice cluster level)

Analysis will compare VLC vs. TA on NCORP practices’
overall ENABLE program implementation measured by
the ENABLE GOI. Due to the small sample size for this
practice cluster-level outcome (24 VLC vs. 24 TA), rather than conducting formal inference testing, comparisons will be descriptive statistics and effect size
measures.
Qualitative analysis The audio-recorded interviews of
the ENABLE GOI will be coded by study team members
(EC-S) [40] in Atlas.ti using a qualitative content analysis
approach using a priori domains from the GOI measure
and additional categories that emerge from the inductive
review of transcripts [65]. Coded data will be aggregated
and reviewed within and across codes to construct an
in-depth understanding of facilitators, barriers, and contextual factors that may influence implementation of the
ENABLE program.
Findings from the qualitative data will be integrated
with the main findings of the RCT at the interpretation
and reporting stage [66]. We will use a convergent
mixed methods analysis to collect both qualitative and
quantitative ENABLE GOI data at roughly the same
time, assess information using parallel constructs for
both types of data, separately analyze both types of data,
and then compare results through discussion and jointly
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displaying both forms of data. The joint display will map
each ENABLE GOI domain score to corresponding concepts or themes from these qualitative findings to more
fully understand the context of the GOI domain scores
and identify patterns across practice clusters [67]. This
will provide validation for each data type and create a
foundation for drawing conclusions about the implementation of the ENABLE program [68].
Analysis for exploratory aims (patient and caregiver outcomes)

Exploratory aim 1 To compare NCORP practices randomized to VLC or TA on patient and caregiver quality
of life and mood, linear mixed models will be used to estimate differences in patient and caregiver outcome trajectories over the 24-week follow-up period. If necessary,
a false discovery rate adjustment will be used to adjust
for multiple exploratory inferences [69].
Exploratory aim 2 The association between ENABLE
sessions and change in patient outcomes will be examined with linear mixed models. Adjusting covariates will
include patient characteristics that may influence participation in sessions (e.g., sex, illness acuity, age). Linear
mixed models will also be used to examine the association between GOI scores and patient outcomes.

Discussion
The relative strengths of learning collaboratives compared to other implementation strategies are poorly
understood [16, 17]. This study will provide a direct
comparison between the VLC and TA strategies to determine if VLC is a superior method to facilitate implementation of the evidence-based ENABLE program in
community-based oncology practices. Finding successful
strategies to implement models of early palliative care in
cancer is imperative given national guidelines that have
highlighted this priority [70].
Most published studies on VLCs are descriptive and
have not definitively tested its effectiveness to enhance
adoption and implementation [16, 71–82]. There are
also few randomized-clinical trials that evaluate traditional in-person learning collaboratives [14, 15, 21, 22]
or compare their effectiveness to other implementation
approaches [16, 17, 71, 83]. For example, learning collaboratives have been shown to outperform financial incentives or toolkits, but only on some process or secondary
outcomes [16, 17]. This study will contribute to the
fields of implementation science and palliative care as
we will learn about the implementation effectiveness of
VLC and TA while delivering an evidence-based practice. While we hypothesize the VLC will outperform TA
due to the shared wisdom generated by the group, the
VLC strategy has greater demands for sites and
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facilitators (and possibly costs) and has less opportinuity
for individual attention than TA. As such, it is important
to assess the added value of each strategy in order to
know how to better spread and sustain EPC. Therefore,
this study will inform efforts to more widely disseminate
ENABLE, while simultaneously advancing implementation science methods and approaches that can be used
for other evidence-based practices.
Like most research, we have encountered challenges
during the study start-up period. First, the COVID-19
pandemic significantly impacted the ability for NCORP
practices to conduct research and resulted in a need to
rely on telehealth. Although most ENABLE activities were
already offered via telephone, we modified the protocol so
that all study procedures can now be conducted remotely,
including the consent process and the comprehensive palliative care assessment. During this time, NCORP practices also expressed concern about the time required to
complete the Nurse Coach training. To reduce training
burden, the length of the web-based ENABLE Nurse
Coach training was reduced from 25 h to approximately
19 h. We anticipate the reduced number of training hours
may be beneficial beyond the study given our goal to make
the ENABLE training more broadly scalable to nurses and
advanced practice providers interested in implementing
this EPC program. We also amended the originally required cohort size (n = 16) and will permit cohorts of 8–
20 practice clusters (4–10 per study arm). To account for
this in analyses, we will assess for confounding by cohort.
Lastly, although each practice cluster will be expected to
deliver ENABLE to 15–27 patients, we recognize that may
not happen. To account for this, we will include an option
to recruit additional practice clusters (up to 20% of 48
which is 58 practices) and additional cohorts. Despite
these challenges, we anticipate the first cohort will launch
in the first half of 2021.
There are several anticipated lessons learned from this
study. First, to the best of our knowledge, this is the first
large-scale study measuring the implementation of early
palliative care in community-based oncology practices.
To measure implementation, we developed and refined
palliative care implementation measures and anticipate
that lessons learned will be used to improve these measures. Second, this study not only seeks to identify the
superior implementation strategy (VLC or TA), but also
to examine the key components of each strategy. To do
so, we have developed measures of participation, engagement, and fidelity that have not been applied in other
published literature. Lessons learned will inform refinement of the measures and advance the field.
Strengths and limitations

There are several strengths to this study. First, this study
will evaluate both the uptake of an evidence-based EPC
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intervention and organizational factors associated with
improving delivery of EPC in community based care.
Second is the collaboration with the URCC NCORP.
Conducting this work outside a consortium would be
difficult, particularly with respect to recruiting practice
clusters. Third, this study provides a solution to the limited palliative care workforce by implementing this program as a generalist palliative care model [84]. As part
of study activities, Nurse Coaches will be trained on how
to deliver the ENABLE EPC program, thereby increasing
practice capacity to offer palliative care services [7, 8,
85]. A final, yet unanticipated strength to this study is
the opportunity to implement the effective ENABLE
EPC telehealth model in community oncology clinics
during COVID-19 when telehealth services are particularly important.
While this study will contribute to implementation science methods and approaches, there are limitations. Patients and caregivers will not know which study arm
their practice cluster is assigned. However, practice clusters will not be blinded to study aims and hypotheses as
sharing those are essential to study recruitment and consent procedures. Similarly, blinding the TA and VLC facilitators and the assessors (e.g., ENABLE GOI
interviewer) to the group assignment is not feasible.
However, it is feasible to limit their knowledge of specific activities in each study arm to minimize bias. Contamination between practice cluster cohorts is another
potential limitation. Since all practice clusters will be affiliated with URCC NCORP, enrolled practice clusters
may discuss their study involvement with practices that
register for a future cohort. To minimize potential contamination between cohorts, we will instruct second and
third cohorts to reach out to the TA or VLC members
(depending on randomization assignment) as opposed to
outside practices for advice.

Conclusion
The results from this study will be twofold: [1] we will
learn about the implementation of an early palliative
care intervention among community oncology practices,
and [2] we will learn about the effectiveness of the VLC
as compared to TA to facilitate such implementation. In
addition, lessons learned will advance the field of implementation science through further refinement of palliative care implementation measures and of the VLC
implementation strategy.
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